Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

NCT05578820

Conditions
Anus Diseases, Anus Neoplasms, Breast Diseases, +47 more
Locations
  • GBUZ Moscow Clinical Scientific Center named after Loginov MHD Moscow, Russia
  • FSBI N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia Moscow, Russia
  • FSBI National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Health of Russia Moscow, Russia
  • National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation Moscow, Russia
View Trial Details
Completed

A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping

NCT02509598

Conditions
Melanoma, Myosarcoma, Neoplasms, +14 more
Locations
  • Nemours Children's Specialty Care Jacksonville, Florida, United States
  • Nemours Children's Hopsital Orlando, Florida, United States
  • Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
View Trial Details
Completed

Radiotherapy or Imiquimod in Complex Lentigo Maligna

NCT02394132

Conditions
Hutchinson's Melanotic Freckle, Lentigo Maligna, Melanoma, +7 more
Locations
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Melanoma Institute Australia North Sydney, New South Wales, Australia
  • Skin and Cancer Foundation Sydney, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
View Trial Details
Completed

Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma

NCT03484923

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • UCSF Medical Center . San Francisco, California, United States
  • Massachusetts General Hospital Massachusetts Gen. Hospital CC Boston, Massachusetts, United States
View all 30 locations
View Trial Details

Related conditions